Icatibant Injection
Product Images NDC 46708-654

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 46708-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Icatibant-fig-a (Icatibant Fig A)

An instructional illustration showing the components of a prefilled syringe for injection, including the plunger, syringe barrel, and protective cap over the syringe tip. It also depicts a capped needle with a needle cap lid, needle, and needle cap, along with an alcohol wipe packet noted as not included in the carton.*

FDA Label Image

Icatibant-fig-b (Icatibant Fig B)

An instructional illustration showing hands opening the carton of Icatibant Injection 30 mg/3 mL (10 mg/mL) prefilled syringe for subcutaneous use. The carton contents include the prefilled syringe and a separate needle displayed inside the packaging.*

FDA Label Image

Icatibant-fig-c (Icatibant Fig C)

An instructional illustration showing two hands holding a vial or syringe component. One hand is rotating or twisting a cap or stopper off the vial, indicated by a curved arrow pointing counterclockwise. The image visually guides the user on how to remove the vial cap prior to use.*

FDA Label Image

Icatibant-fig-d (Icatibant Fig D)

An instructional illustration showing two hands. One hand holds a small vial, and the other holds a syringe with the needle cap removed, positioned to draw liquid from the vial. A needle cap is shown detached below the syringe, indicating preparation for injection.*

FDA Label Image

Icatibant-fig-e (Icatibant Fig E)

An instructional illustration showing hands holding an injection pen. One hand holds the pen, while the other hand is rotating the cover cap off the needle, indicated by a curved arrow around the cap. The image demonstrates a step in preparing a subcutaneous injection.*

FDA Label Image

Icatibant-fig-f (Icatibant Fig F)

An instructional diagram showing a torso from the back with two shaded rectangular areas on the upper back, indicating the recommended injection sites for subcutaneous administration of a drug.*

FDA Label Image

Icatibant-fig-g (Icatibant Fig G)

Illustration showing a hand positioned to administer a subcutaneous injection in the abdominal area. The image outlines a torso with the hand applying an injection beneath the skin, representing the subcutaneous route typically used for Icatibant injection.*

FDA Label Image

Tibant-fig-h (Icatibant Fig H)

An instructional diagram showing two hands preparing a subcutaneous injection. One hand holds a syringe with a needle pointing toward a vial held by the other hand. An arrow indicates the direction of the syringe toward the vial, suggesting preparation or drawing medication.*

FDA Label Image

Icatibant-fig-i (Icatibant Fig I)

An instructional line drawing showing a hand holding a syringe with needle positioned for a subcutaneous injection. The image illustrates the proper grip for administering an injection, relevant to subcutaneous dosage forms like Icatibant 30 mg/3 mL injection.*

FDA Label Image

Icatibant-fig-j (Icatibant Fig J)

A simple black line drawing illustration showing a human torso with a hand positioned at the abdominal area, demonstrating a subcutaneous injection technique or site.*

FDA Label Image

Icatibant-fig-k (Icatibant Fig K)

An instructional illustration showing two correct angles for subcutaneous injection using a syringe: one at a 45-degree angle and the other at a 90-degree angle relative to the skin surface. The image demonstrates positioning of the syringe and needle for proper injection technique.*

FDA Label Image

Icatibant-fig-l (Icatibant Fig L)

An instructional line drawing showing a hand holding an injection syringe approaching the palm side of another person's forearm, illustrating subcutaneous injection technique.*

FDA Label Image

Icatibant-fig-m (Icatibant Fig M)

An instructional medical illustration showing the administration of a subcutaneous injection into the back of the hand. The image depicts one hand holding a syringe angled toward the skin on the opposite hand, with an arrow indicating the injection direction.*

FDA Label Image

Icatibant-fig-n (Icatibant Fig N)

An instructional illustration showing a hand holding a syringe, directed towards a marked injection site on the abdomen, demonstrating subcutaneous injection technique.*

FDA Label Image

Icatibant-fig-o (Icatibant Fig O)

An instructional black-and-white illustration showing one hand holding a vial while the other hand inserts a syringe into the vial's opening, indicating the action of drawing medication from the vial for injection.*

FDA Label Image

Icatibant-graph (Icatibant Graph)

A Kaplan-Meier curve comparing the proportion of patients not achieving a 50% reduction in symptoms over time following treatment with Icatibant injection versus placebo. The x-axis represents time from dose in hours (0 to 60), and the y-axis represents the proportion of patients not achieving symptom reduction. The graph shows data for 43 patients treated with Icatibant and 45 with placebo.*

FDA Label Image

Icatibant-monocarton-apl (Icatibant Monocarton Apl)

Icatibant Injection 30 mg/3 mL (10 mg/mL) subcutaneous injection packaging label from Alembic Pharmaceuticals Limited. The label states it is for single-dose use with one 3 mL prefilled syringe per carton. It includes storage instructions, inactive ingredients, and contact information. The carton contains one prefilled syringe and one 25G hypodermic needle.*

FDA Label Image

Icatibant-outercarton-apl (Icatibant Outercarton Apl)

Packaging label for Icatibant Injection 30 mg/3 mL (10 mg/mL) subcutaneous injection by Alembic Pharmaceuticals Limited. The label indicates the product is available as 3 x 3 mL single-dose prefilled syringes, for prescription use only. It includes storage instructions and inactive ingredients, with manufacturer details and a barcode.*

FDA Label Image

Icatibant-pfs-label-apl (Icatibant Pfs Label Apl)

The label for Icatibant Injection 30 mg/3 mL (10 mg/mL) displays it is for subcutaneous use, supplied as a 3 mL single-dose prefilled syringe. The label includes the NDC 46708-654-03, manufacturer Alembic Pharmaceuticals Limited located in Gujarat, India, with batch and expiration placeholders. It features branding colors in blue and orange with clear dosage and usage instructions.*

FDA Label Image

Icatibant-structure (Icatibant Structure)

Chemical structure of icatibant, depicting the molecular connectivity and specific functional groups of the active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.